**Question:** True about lactulose is -

A. It is a laxative used for constipation.
B. It is a non-absorbable sugar that passes through the gastrointestinal tract and is excreted without being utilized.
C. It is used as a source of energy for intestinal bacteria.
D. It is an antibiotic that kills harmful bacteria in the gut.

**Correct Answer:** B. It is a non-absorbable sugar that passes through the gastrointestinal tract and is excreted without being utilized.

**Core Concept:** Lactulose is a non-absorbable disaccharide that has several pharmacological effects in the gastrointestinal tract.

**Why the Correct Answer is Right:** Lactulose is used as a treatment for certain liver diseases and neurological disorders, primarily because of its unique pharmacological properties. As a non-absorbable sugar, lactulose does not enter the systemic circulation and does not exert systemic effects. Instead, it acts locally in the gastrointestinal tract:

1. **Bulking agent:** Lactulose is not absorbed from the large intestine, leading to increased stool volume and softening, which promotes bowel movement.
2. **Prevents ammonia absorption:** Lactulose is fermented by gut bacteria into non-toxic substances like hydrogen, methane, and carbon dioxide. This fermentation process reduces ammonia absorption from the gut, which is relevant in treating patients with liver cirrhosis and portosystemic encephalopathy.

**Why Each Wrong Option is Incorrect:**

A. Lactulose is not a laxative for constipation directly. Although it increases stool volume, it is primarily used in liver diseases and neurological disorders, not constipation treatment.

C. Lactulose is not used as a source of energy for intestinal bacteria. It is fermented by gut bacteria, but not utilized as an energy source. Instead, it helps reduce ammonia absorption in certain medical conditions.

D. Lactulose is not an antibiotic that kills harmful bacteria. It is a non-absorbable sugar that promotes fermentation by gut bacteria, not directly affecting harmful bacteria. Its main therapeutic effects are related to ammonia reduction and stool bulking.

**Clinical Pearls:**

Lactulose is a crucial medication in the management of patients with liver cirrhosis and portosystemic encephalopathy. It works by preventing ammonia absorption and promoting bacterial fermentation, which helps to reduce the ammonia concentration in the gastrointestinal tract. This action is particularly beneficial in patients with liver cirrhosis and portosystemic encephalopathy, where ammonia accumulation in the bloodstream leads to neurological dysfunction.

By understanding the pharmacology of lactulose, medical professionals can effectively treat patients with liver cirrhosis and neurological complications associated with ammonia overload.